Yale launches massive blood repository to unlock cancer secrets

NCT ID NCT07689864

Not yet recruiting Knowledge-focused Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study collects blood samples from people with cancer or at high risk for cancer to create a large, well-organized repository for research. The goal is to provide scientists with a valuable resource to study cancer through liquid biopsies, which may lead to better detection and monitoring methods. Participants provide blood samples and optional tumor tissue, which are stored and linked to their medical information for future studies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this repository could enable researchers to develop better ways to detect cancer early, monitor treatment response, and understand cancer biology.
What could go wrong: This is an observational repository study, not a treatment trial. It does not directly test any therapy, and its value depends on future research that may or may not yield results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer hematopoietic and lymphoid cell neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER MOLECULAR RESIDUAL DISEASE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Smilow Cancer Hospital

New Haven, Connecticut, 06519, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.